Tilray Brands, Inc. (TLRY.TO)

2.000.05 (2.56%)

Tilray Brands, Inc. (TLRY.TO) stock comprehensive Forecast and Price Target with Analyst Ratings, Revenue Estimates, and complete financial and advanced discounted cashflow forecasts for up to 10 years.

High Bankruptcy RiskFair ValuationLow ProfitabilityAdequate Financial HealthModerate EfficiencyModerate GrowthLow QualityAdequate Dividend ProfileIndustry Rank: 44.14%Sector Rank: 55.17%

TSX - Healthcare - Drug Manufacturers - Specialty & Generic | Market Cap: 2.20B | Next Earnings Date: 9 Oct 2025

Day's Range

1.90 - 2.15

52-Week Range

0.48 - 2.54

Volume

9.88M / 3.06M (Avg.)

P/E Ratio | EPS

-0.59 | -3.40

Trending:

Analyst Consensus

Compare with Competitor

None WEED.TO ACB.TO TLRY OGI.TO CRON.TO

View analysts' price targets and recommendations, and compare them with competitors.

Analyst Price Target

No Data

No price target data available for this metric.

Analyst Recommendation

Hold

Positive consensus among analysts.

Financial Forecasts for May 2025

Select Date

May 2030 May 2029 May 2028 May 2027 May 2026 May 2025

Compare with Competitor

None WEED.TO ACB.TO TLRY

Analyze analyst forecasts for the company and compare them with competitors.

Estimated Revenue

1.30B

Increased from previous period

Low: 1.25B | High: 1.37B

The estimated revenue has increased from the previous period.

Estimated EBITDA

-509.05M

Decreased from previous period

Low: -535.73M | High: -488.06M

The estimated EBITDA has decreased from the previous period.

Estimated EPS

-0.18

Increased from previous period

Low: -0.33 | High: 0.09

The estimated EPS has increased from the previous period.

Estimated Net Income

-132.07M

Increased from previous period

Low: -241.60M | High: 64.43M

The estimated net income has increased from the previous period.

Estimated EBIT

-626.86M

Decreased from previous period

Low: -659.72M | High: -601.01M

The estimated EBIT has decreased from the previous period.

Estimated SG&A Expense

430.67M

Increased from previous period

Low: 412.91M | High: 453.24M

The estimated SG&A expenses have increased from the previous period.

Select Metric for Chart

Discounted Cash Flow Forecasts for 2022

Select Year

2030 2029 2028 2027 2026 2025

Compare with Competitor

None OGI.TO HEXO.TO CRON.TO

Analyze DCF forecasts for the company and compare them with competitors.

Revenue

906.23M

No peer data available for comparison.

Revenue Growth Rate

22.47%

No peer data available for comparison.

EBITDA

-355.36M

No peer data available for comparison.

EBITDA Margin

-39.21%

No peer data available for comparison.

EBIT

-521.49M

No peer data available for comparison.

EBIT Margin

-57.54%

No peer data available for comparison.

Depreciation

166.13M

No peer data available for comparison.

Total Cash

599.82M

No peer data available for comparison.

Cash as Percentage of Revenue

66.19%

No peer data available for comparison.

Receivables

137.41M

No peer data available for comparison.

Receivables as Percentage of Revenue

15.16%

No peer data available for comparison.

Inventories

354.10M

No peer data available for comparison.

Inventories as Percentage of Revenue

39.07%

No peer data available for comparison.

Accounts Payable

98.94M

No peer data available for comparison.

Payables as Percentage of Revenue

10.92%

No peer data available for comparison.

Capital Expenditure

-49.13M

No peer data available for comparison.

CapEx as Percentage of Revenue

-5.42%

No peer data available for comparison.

Weighted Average Cost of Capital (WACC)

14.20%

No peer data available for comparison.

Cost of Equity

14.92%

No peer data available for comparison.

Cost of Debt

12.72%

No peer data available for comparison.

Beta

2.19

No peer data available for comparison.

Diluted Shares Outstanding

742.65M

No peer data available for comparison.

Total Debt

558.58M

No peer data available for comparison.

Total Equity

1.30B

No peer data available for comparison.

Total Capital

1.86B

No peer data available for comparison.

Debt Weighting

30.06%

No peer data available for comparison.

Equity Weighting

69.94%

No peer data available for comparison.

EBIAT

-513.74M

No peer data available for comparison.

Unlevered Free Cash Flow

-373.22M

No peer data available for comparison.

Long-Term Growth Rate

2.00%

No peer data available for comparison.

Terminal Value

-11.86B

No peer data available for comparison.

Enterprise Value

-9.55B

No peer data available for comparison.

Net Debt

229.28M

No peer data available for comparison.

Equity Value

-9.78B

No peer data available for comparison.

Equity Value Per Share

-13.17

No peer data available for comparison.

Select Metric for Chart

Discounted Cash Flow Forecasts for 2022

Select Year

2030 2029 2028 2027 2026 2025

Compare with Competitor

None OGI.TO HEXO.TO CRON.TO

Analyze DCF forecasts for the company and compare them with competitors.

Revenue

906.23M

No peer data available for comparison.

Revenue Growth Rate

22.47%

No peer data available for comparison.

EBITDA

-355.36M

No peer data available for comparison.

EBITDA Margin

-39.21%

No peer data available for comparison.

EBIT

-521.49M

No peer data available for comparison.

EBIT Margin

-57.54%

No peer data available for comparison.

Depreciation

166.13M

No peer data available for comparison.

Total Cash

599.82M

No peer data available for comparison.

Cash as Percentage of Revenue

66.19%

No peer data available for comparison.

Receivables

137.41M

No peer data available for comparison.

Receivables as Percentage of Revenue

15.16%

No peer data available for comparison.

Inventories

354.10M

No peer data available for comparison.

Inventories as Percentage of Revenue

39.07%

No peer data available for comparison.

Accounts Payable

98.94M

No peer data available for comparison.

Payables as Percentage of Revenue

10.92%

No peer data available for comparison.

Capital Expenditure

-49.13M

No peer data available for comparison.

CapEx as Percentage of Revenue

-5.42%

No peer data available for comparison.

Weighted Average Cost of Capital (WACC)

14.20%

No peer data available for comparison.

Cost of Equity

14.92%

No peer data available for comparison.

Cost of Debt

12.72%

No peer data available for comparison.

Beta

2.19

No peer data available for comparison.

Diluted Shares Outstanding

742.65M

No peer data available for comparison.

Total Debt

558.58M

No peer data available for comparison.

Total Equity

1.30B

No peer data available for comparison.

Total Capital

1.86B

No peer data available for comparison.

Debt Weighting

30.06%

No peer data available for comparison.

Equity Weighting

69.94%

No peer data available for comparison.

EBIAT

-513.74M

No peer data available for comparison.

Unlevered Free Cash Flow

-373.22M

No peer data available for comparison.

Long-Term Growth Rate

2.00%

No peer data available for comparison.

Terminal Value

-11.86B

No peer data available for comparison.

Enterprise Value

-9.55B

No peer data available for comparison.

Net Debt

229.28M

No peer data available for comparison.

Equity Value

-9.78B

No peer data available for comparison.

Equity Value Per Share

-13.17

No peer data available for comparison.

Select Metric for Chart